HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central effects of zomepirac on pain evoked by intraneural stimulation in man.

Abstract
The central analgesic activity of zomepirac was studied in six healthy subjects by means of intraneural electrical stimulation. Pain elicited by selective activation of nociceptive fibers was inhibited by the administration of a single oral dose of 100 mg zomepirac. Pain relief in this double-blind crossover study was significantly greater after zomepirac than after placebo. Maximal analgesic effect was observed between 30 and 90 minutes after ingestion. Since peripheral receptors are bypassed by this technique, it is postulated that the observed effect reflects a central action of zomepirac, possibly as a result of inhibition of prostaglandin synthesis in the central nervous system.
AuthorsW Schady, H E Torebjörk
JournalJournal of clinical pharmacology (J Clin Pharmacol) Vol. 24 Issue 10 Pg. 429-35 (Oct 1984) ISSN: 0091-2700 [Print] England
PMID6511987 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pyrroles
  • zomepirac
  • Tolmetin
Topics
  • Adolescent
  • Adult
  • Double-Blind Method
  • Electric Stimulation
  • Humans
  • Neurons (physiology)
  • Pain (drug therapy)
  • Pyrroles (therapeutic use)
  • Tolmetin (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: